(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202309 | 202209 | % Var | 202309 | 202209 | % Var | 202303 | 202203 | % Var | |
| Sales | 34.94 | 25.51 | 36.97 | 75.56 | 79.06 | -4.43 | 131.29 | 223.62 | -41.29 |
| Other Income | 0.45 | 0.39 | 15.38 | 0.45 | 0.39 | 15.38 | 3.76 | 5.22 | -27.97 |
| PBIDT | 1.76 | 1.37 | 28.47 | 4.84 | 3.41 | 41.94 | 4.06 | 9.80 | -58.57 |
| Interest | 0.05 | 0.02 | 150.00 | 0.06 | 0.05 | 20.00 | 0.07 | 0.13 | -46.15 |
| PBDT | 1.71 | 1.35 | 26.67 | 4.78 | 3.36 | 42.26 | 3.99 | 9.63 | -58.57 |
| Depreciation | 0.55 | 0.66 | -16.67 | 1.07 | 1.41 | -24.11 | 2.80 | 3.58 | -21.79 |
| PBT | 1.16 | 0.69 | 68.12 | 3.71 | 1.95 | 90.26 | 1.19 | 6.05 | -80.33 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.40 | 2.95 | -86.44 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 1.13 | -92.04 |
| PAT | 1.16 | 0.69 | 68.12 | 3.71 | 1.95 | 90.26 | 0.79 | 3.10 | -74.52 |
| Equity | 53.74 | 53.74 | 0.00 | 53.74 | 53.74 | 0.00 | 53.74 | 53.74 | 0.00 |
| PBIDTM(%) | 5.04 | 5.37 | -6.20 | 6.41 | 4.31 | 48.51 | 3.09 | 4.38 | -29.44 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1820.75 |
| Dr. Reddys Lab | 1270.95 |
| Cipla | 1333.55 |
| Zydus Lifesciences | 911.85 |
| Lupin | 2343.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: